Renalytix Ownership 2024 | Who Owns Renalytix Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

5.16%

Insider Ownership

4.51%

Retail Ownership

90.33%

Institutional Holders

13.00

Renalytix Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PINNACLE ASSOCIATES LTD1.67%0.00%815,425119,42017.16%188,363Jun 30, 2024
STIFEL FINANCIAL CORP1.15%0.00%561,0002,6000.47%129,593Jun 30, 2024
LEVIN CAPITAL STRATEGIES, L.P.1.14%0.01%555,000555,000100.00%128,205Jun 30, 2024
TEJARA CAPITAL LTD1.02%0.04%500,394--115,591Jun 30, 2024
CI PRIVATE WEALTH, LLC0.69%0.00%335,514--77,504Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC0.24%0.00%117,644--27,176Jun 30, 2024
CANTOR FITZGERALD, L. P.0.24%0.01%115,000115,000100.00%26,565Jun 30, 2024
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC0.13%-63,739--14,724Jun 30, 2024
TRAYNOR CAPITAL MANAGEMENT, INC.0.12%0.00%60,00060,000100.00%13,860Jun 30, 2024
NORTH STAR INVESTMENT MANAGEMENT CORP.0.09%0.00%43,000--9,933Jun 30, 2024
CVI HOLDINGS, LLC0.08%0.01%38,34638,346100.00%8,858Jun 30, 2024
TWO SIGMA SECURITIES, LLC0.05%0.00%24,6831,3575.82%5,702Jun 30, 2024
LPL FINANCIAL LLC0.04%-18,375--4,245Jun 30, 2024
EWA, LLC0.03%0.00%16,486-11,888-41.90%5,051Jun 30, 2024
JPMORGAN CHASE & CO0.03%-16,165-25,831-61.51%3,734Jun 30, 2024
VIRTU FINANCIAL LLC0.03%0.00%12,495-1,798-12.58%3,000Jun 30, 2024
IRONWOOD INVESTMENT COUNSEL, LLC0.02%0.00%12,000--2,772Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.02%-10,68510,5658804.17%2,469Jun 30, 2024
MORGAN STANLEY0.01%-6,4563,433113.56%1,491Jun 30, 2024
GROUP ONE TRADING, L.P.0.00%-174-100-36.50%40,000Jun 30, 2024

Renalytix's largest institutional shareholder is PINNACLE ASSOCIATES LTD, holding 1.67% of the company's total share outstanding, currently valued at $188.36K. The top 10 institutional shareholders own together 6.49% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
TEJARA CAPITAL LTD1.02%0.04%500,394--115,591Jun 30, 2024
LEVIN CAPITAL STRATEGIES, L.P.1.14%0.01%555,000555,000100.00%128,205Jun 30, 2024
CVI HOLDINGS, LLC0.08%0.01%38,34638,346100.00%8,858Jun 30, 2024
CANTOR FITZGERALD, L. P.0.24%0.01%115,000115,000100.00%26,565Jun 30, 2024
PINNACLE ASSOCIATES LTD1.67%0.00%815,425119,42017.16%188,363Jun 30, 2024
EWA, LLC0.03%0.00%16,486-11,888-41.90%5,051Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC0.24%0.00%117,644--27,176Jun 30, 2024
TRAYNOR CAPITAL MANAGEMENT, INC.0.12%0.00%60,00060,000100.00%13,860Jun 30, 2024
NORTH STAR INVESTMENT MANAGEMENT CORP.0.09%0.00%43,000--9,933Jun 30, 2024
IRONWOOD INVESTMENT COUNSEL, LLC0.02%0.00%12,000--2,772Jun 30, 2024
VIRTU FINANCIAL LLC0.03%0.00%12,495-1,798-12.58%3,000Jun 30, 2024
STIFEL FINANCIAL CORP1.15%0.00%561,0002,6000.47%129,593Jun 30, 2024
CI PRIVATE WEALTH, LLC0.69%0.00%335,514--77,504Jun 30, 2024
TWO SIGMA SECURITIES, LLC0.05%0.00%24,6831,3575.82%5,702Jun 30, 2024
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC0.13%-63,739--14,724Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.02%-10,68510,5658804.17%2,469Jun 30, 2024
LPL FINANCIAL LLC0.04%-18,375--4,245Jun 30, 2024
JPMORGAN CHASE & CO0.03%-16,165-25,831-61.51%3,734Jun 30, 2024
GROUP ONE TRADING, L.P.0.00%-174-100-36.50%40,000Jun 30, 2024
MORGAN STANLEY0.01%-6,4563,433113.56%1,491Jun 30, 2024

The largest Renalytix shareholder by % of total assets is TEJARA CAPITAL LTD. The company owns 500.39K shares of Renalytix (RNLX), representing 0.04% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
LEVIN CAPITAL STRATEGIES, L.P.1.14%0.01%555,000555,000100.00%128,205Jun 30, 2024
PINNACLE ASSOCIATES LTD1.67%0.00%815,425119,42017.16%188,363Jun 30, 2024
CANTOR FITZGERALD, L. P.0.24%0.01%115,000115,000100.00%26,565Jun 30, 2024
TRAYNOR CAPITAL MANAGEMENT, INC.0.12%0.00%60,00060,000100.00%13,860Jun 30, 2024
CVI HOLDINGS, LLC0.08%0.01%38,34638,346100.00%8,858Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.02%-10,68510,5658804.17%2,469Jun 30, 2024
MORGAN STANLEY0.01%-6,4563,433113.56%1,491Jun 30, 2024
STIFEL FINANCIAL CORP1.15%0.00%561,0002,6000.47%129,593Jun 30, 2024
TWO SIGMA SECURITIES, LLC0.05%0.00%24,6831,3575.82%5,702Jun 30, 2024
UBS GROUP AG0.00%-7575100.00%17Jun 30, 2024
LPL FINANCIAL LLC0.04%-18,375--4,245Jun 30, 2024
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC0.13%-63,739--14,724Jun 30, 2024
CI PRIVATE WEALTH, LLC0.69%0.00%335,514--77,504Jun 30, 2024
IRONWOOD INVESTMENT COUNSEL, LLC0.02%0.00%12,000--2,772Jun 30, 2024
NORTH STAR INVESTMENT MANAGEMENT CORP.0.09%0.00%43,000--9,933Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC0.24%0.00%117,644--27,176Jun 30, 2024
TEJARA CAPITAL LTD1.02%0.04%500,394--115,591Jun 30, 2024
PARALLEL ADVISORS, LLC----60-100.00%-Jun 30, 2024
GROUP ONE TRADING, L.P.0.00%-174-100-36.50%40,000Jun 30, 2024
WELLS FARGO & COMPANY/MN----175-100.00%-Jun 30, 2024

As of Jun 30 2024, Renalytix's largest institutional buyer is LEVIN CAPITAL STRATEGIES, L.P.. The company purchased 555.00K stocks of RNLX, valued at $128.21K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
GILDER GAGNON HOWE & CO LLC----761,108-100.00%-Jun 30, 2024
PENTWATER CAPITAL MANAGEMENT LP----630,000-100.00%-Jun 30, 2024
LAZARD ASSET MANAGEMENT LLC----125,478-100.00%-Jun 30, 2024
HRT FINANCIAL LP----31,523-100.00%-Jun 30, 2024
JPMORGAN CHASE & CO0.03%-16,165-25,831-61.51%3,734Jun 30, 2024
XTX TOPCO LTD----24,588-100.00%-Jun 30, 2024
MILLENNIUM MANAGEMENT LLC----13,883-100.00%-Jun 30, 2024
EWA, LLC0.03%0.00%16,486-11,888-41.90%5,051Jun 30, 2024
CLEAR STREET MARKETS LLC----1,809-100.00%-Jun 30, 2024
VIRTU FINANCIAL LLC0.03%0.00%12,495-1,798-12.58%3,000Jun 30, 2024
WELLS FARGO & COMPANY/MN----175-100.00%-Jun 30, 2024
GROUP ONE TRADING, L.P.0.00%-174-100-36.50%40,000Jun 30, 2024
PARALLEL ADVISORS, LLC----60-100.00%-Jun 30, 2024
TEJARA CAPITAL LTD1.02%0.04%500,394--115,591Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC0.24%0.00%117,644--27,176Jun 30, 2024
NORTH STAR INVESTMENT MANAGEMENT CORP.0.09%0.00%43,000--9,933Jun 30, 2024
IRONWOOD INVESTMENT COUNSEL, LLC0.02%0.00%12,000--2,772Jun 30, 2024
CI PRIVATE WEALTH, LLC0.69%0.00%335,514--77,504Jun 30, 2024
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC0.13%-63,739--14,724Jun 30, 2024
LPL FINANCIAL LLC0.04%-18,375--4,245Jun 30, 2024

As of Jun 30 2024, Renalytix's biggest institutional seller is GILDER GAGNON HOWE & CO LLC. The company sold -0.76M shares of RNLX, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
LEVIN CAPITAL STRATEGIES, L.P.1.14%0.01%555,000555,000100.00%128,205Jun 30, 2024
CANTOR FITZGERALD, L. P.0.24%0.01%115,000115,000100.00%26,565Jun 30, 2024
TRAYNOR CAPITAL MANAGEMENT, INC.0.12%0.00%60,00060,000100.00%13,860Jun 30, 2024
CVI HOLDINGS, LLC0.08%0.01%38,34638,346100.00%8,858Jun 30, 2024
UBS GROUP AG0.00%-7575100.00%17Jun 30, 2024

Renalytix's largest new institutional shareholder by number of shares is LEVIN CAPITAL STRATEGIES, L.P., purchased 555.00K shares, valued at $128.21K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
GILDER GAGNON HOWE & CO LLC----761,108-100.00%-Jun 30, 2024
PENTWATER CAPITAL MANAGEMENT LP----630,000-100.00%-Jun 30, 2024
LAZARD ASSET MANAGEMENT LLC----125,478-100.00%-Jun 30, 2024
HRT FINANCIAL LP----31,523-100.00%-Jun 30, 2024
XTX TOPCO LTD----24,588-100.00%-Jun 30, 2024
MILLENNIUM MANAGEMENT LLC----13,883-100.00%-Jun 30, 2024
CLEAR STREET MARKETS LLC----1,809-100.00%-Jun 30, 2024
WELLS FARGO & COMPANY/MN----175-100.00%-Jun 30, 2024
PARALLEL ADVISORS, LLC----60-100.00%-Jun 30, 2024

Renalytix's largest sold out institutional shareholder by shares sold is GILDER GAGNON HOWE & CO LLC, sold -0.76M shares, valued at -, as of undefined.

Renalytix Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
ALGER INSTITUTIONAL FUNDS0.28%72,215--Jan 31, 2024
ALGER PORTFOLIOS0.18%68,833--Dec 31, 2023
ALGER FUNDS0.17%165,345--Jan 31, 2024
MERIDIAN FUND INC0.10%231,243--Mar 28, 2024
AMG FUNDS III0.01%34,048--Mar 28, 2024
ALLSPRING MASTER TRUST0.00%264,028--Feb 29, 2024
Destra Investment Trust0.00%4,545--Mar 31, 2024
Harbor ETF Trust0.00%3,710--Jan 31, 2024
USAA MUTUAL FUNDS TRUST0.00%25,288--Jan 31, 2024
SPDR INDEX SHARES FUNDS0.00%20,905--Mar 31, 2024
Goldman Sachs ETF Trust0.00%9,493--Feb 29, 2024
FIDELITY CONCORD STREET TRUST0.00%4,865--Feb 29, 2024
WILSHIRE MUTUAL FUNDS INC0.00%1,941--Dec 31, 2023
SEI INSTITUTIONAL MANAGED TRUST0.00%17,363--Dec 31, 2023
Blackstone Alternative Investment Funds0.00%100--Mar 31, 2023
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%4,388--Feb 29, 2024

Renalytix's largest mutual fund holder by % of total assets is "ALGER INSTITUTIONAL FUNDS", owning 72.22K shares, compromising 0.28% of its total assets.

Renalytix Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 2413-48.00%
31 Mar, 2425-
31 Dec, 2325-7.41%
30 Sep, 232722.73%
30 Jun, 23224.76%
31 Mar, 2321-12.50%
31 Dec, 2224-14.29%
30 Sep, 2228-12.50%
30 Jun, 2232-11.11%
31 Mar, 2236-5.26%
31 Dec, 213815.15%
30 Sep, 2133-29.79%
30 Jun, 21479.30%
31 Mar, 2143115.00%
31 Dec, 202025.00%
30 Sep, 20161500.00%
30 Jun, 201-

As of 30 Jun 24, 13 institutions are holding Renalytix's shares, representing a decrease of -48.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 242,519,884-37.71%
31 Mar, 244,045,1016.07%
31 Dec, 233,813,493-10.54%
30 Sep, 234,262,66919.49%
30 Jun, 233,567,4228.39%
31 Mar, 233,291,309-4.99%
31 Dec, 223,464,096-21.67%
30 Sep, 224,422,605-22.22%
30 Jun, 225,686,044-10.13%
31 Mar, 226,327,0835.29%
31 Dec, 216,009,450-0.93%
30 Sep, 216,065,8281.96%
30 Jun, 215,949,0650.23%
31 Mar, 215,935,16422.40%
31 Dec, 204,848,860-1.16%
30 Sep, 204,905,576155632.57%
30 Jun, 203,150-

Renalytix (RNLX) has 2.52M shares outstanding as of 30 Jun 24, down -37.71% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 245.16%7.46%
31 Mar, 248.32%54396607.69%
31 Dec, 230.00%0.00%
30 Sep, 2310.37%14.91%
30 Jun, 238.34%14.09%
31 Mar, 237.69%8.99%
31 Dec, 229.25%6.62%
30 Sep, 2211.82%4.85%
30 Jun, 2215.61%5.09%
31 Mar, 2217.50%6.33%
31 Dec, 2116.63%5.89%
30 Sep, 2116.80%6.06%
30 Jun, 2116.64%6.13%
31 Mar, 2116.48%9.09%
31 Dec, 2013.46%6.82%
30 Sep, 2014.05%12312702.80%
30 Jun, 200.01%-

As of 30 Jun 24, Renalytix is held by 5.16% institutional shareholders, representing a 7.46% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 245-50.00%
31 Mar, 2410-9.09%
31 Dec, 2311-21.43%
30 Sep, 2314-12.50%
30 Jun, 231660.00%
31 Mar, 2310-23.08%
31 Dec, 2213-27.78%
30 Sep, 221850.00%
30 Jun, 2212-47.83%
31 Mar, 22239.52%
31 Dec, 212110.53%
30 Sep, 2119-9.52%
30 Jun, 2121-25.00%
31 Mar, 2128154.55%
31 Dec, 2011-26.67%
30 Sep, 20151400.00%
30 Jun, 201-

5 institutional shareholders have increased their position in RNLX stock as of 30 Jun 24 compared to 10 in the previous quarter (a -50.00% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 243-72.73%
31 Mar, 241137.50%
31 Dec, 238-11.11%
30 Sep, 239125.00%
30 Jun, 234-33.33%
31 Mar, 236-14.29%
31 Dec, 22740.00%
30 Sep, 225-58.33%
30 Jun, 221250.00%
31 Mar, 228-20.00%
31 Dec, 211042.86%
30 Sep, 217-22.22%
30 Jun, 21912.50%
31 Mar, 21860.00%
31 Dec, 205-
30 Sep, 20--
30 Jun, 20--

3 institutional shareholders have reduced their position in RNLX stock as of 30 Jun 24 compared to 11 in the previous quarter (a -72.73% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 2413-48.00%2,519,884-37.71%5.16%7.46%5-50.00%3-72.73%
31 Mar, 2425-4,045,1016.07%8.32%54396607.69%10-9.09%1137.50%
31 Dec, 2325-7.41%3,813,493-10.54%0.00%0.00%11-21.43%8-11.11%
30 Sep, 232722.73%4,262,66919.49%10.37%14.91%14-12.50%9125.00%
30 Jun, 23224.76%3,567,4228.39%8.34%14.09%1660.00%4-33.33%
31 Mar, 2321-12.50%3,291,309-4.99%7.69%8.99%10-23.08%6-14.29%
31 Dec, 2224-14.29%3,464,096-21.67%9.25%6.62%13-27.78%740.00%
30 Sep, 2228-12.50%4,422,605-22.22%11.82%4.85%1850.00%5-58.33%
30 Jun, 2232-11.11%5,686,044-10.13%15.61%5.09%12-47.83%1250.00%
31 Mar, 2236-5.26%6,327,0835.29%17.50%6.33%239.52%8-20.00%
31 Dec, 213815.15%6,009,450-0.93%16.63%5.89%2110.53%1042.86%
30 Sep, 2133-29.79%6,065,8281.96%16.80%6.06%19-9.52%7-22.22%
30 Jun, 21479.30%5,949,0650.23%16.64%6.13%21-25.00%912.50%
31 Mar, 2143115.00%5,935,16422.40%16.48%9.09%28154.55%860.00%
31 Dec, 202025.00%4,848,860-1.16%13.46%6.82%11-26.67%5-
30 Sep, 20161500.00%4,905,576155632.57%14.05%12312702.80%151400.00%--
30 Jun, 201-3,150-0.01%-1---

Renalytix Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 03, 2023Sterling O. Jamesofficer Chief Financial OfficerSell---1,805,236
Jul 03, 2023Scannell Timothy Jdirector-Sell---68,964
Jul 03, 2023Scannell Timothy Jdirector-Sell40,000---
Jul 03, 2023Parikh Chirag R.director-Sell50,000---

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 13, 2024Jung Joel Rofficer Interim Chief Financial OfficeA-AwardBuy60,000$0.21$12.40K60,000
Jun 05, 2024Jung Joel R-Buy----
Apr 26, 2024ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI10 percent owner-J-OtherBuy9,360,374$0.25$2.34M19,317,248
Nov 22, 2023Coste Catherinedirector-A-AwardBuy95,000$0.30$28.88K95,000
Nov 22, 2023LEVANGIE DANIEL Jdirector-A-AwardBuy95,000$0.30$28.88K95,000
Nov 22, 2023Parikh Chirag R.director-A-AwardBuy95,000$0.30$28.88K95,000
Nov 22, 2023MILLS CHRISTOPHERdirector, 10 percent owner A-AwardBuy95,000$0.30$28.88K95,000
Nov 22, 2023Doran Howard JRofficer Chief Business OfficerA-AwardBuy300,000$0.30$91.20K300,000
Sep 12, 2023Doran Howard JRofficer-Buy----
Jul 11, 2023MCLAIN THOMAS Hofficer PresidentA-AwardBuy200,000--200,000
Jul 07, 2023Donovan Michael J.officer Chief Medical OfficerA-AwardBuy85,731--85,731
Jul 07, 2023Coste Catherinedirector-A-AwardBuy190,000--190,000
Jul 07, 2023McCullough James Renwickdirector, officer Chief Executive OfficerA-AwardBuy875,017--875,017
Jul 07, 2023MCLAIN THOMAS Hofficer PresidentA-AwardBuy394,486--394,486
Jul 07, 2023Fleming Fergusdirector, officer Chief Technical OfficerA-AwardBuy352,902--352,902
Jul 07, 2023Sterling O. Jamesofficer Chief Financial OfficerA-AwardBuy575,160--575,160
Jul 03, 2023Sterling O. Jamesofficer Chief Financial OfficerSell---1,805,236
Jul 03, 2023Scannell Timothy Jdirector-Sell---68,964
Jul 03, 2023Scannell Timothy Jdirector-Sell40,000---
Jul 03, 2023Parikh Chirag R.director-Sell50,000---

The last insider sell of Renalytix's stock was made by Sterling O. James on Jul 03 2023, selling - shares at - per share (valued at -).

Renalytix Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20242--
Q4 20235--
Q3 202371450.00%

2 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Renalytix's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024---
Q4 2023---
Q3 2023---

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Renalytix's stocks.

Renalytix Peer Ownership


TickerCompany
SNCEScience 37 Holdings, Inc.
FORAForian Inc.
NRCNational Research Corporation
PGNYProgyny, Inc.
AKLIAkili, Inc.
STRMStreamline Health Solutions, Inc.
MGRXMangoceuticals, Inc.
CPSITruBridge, Inc.
HQYHealthEquity, Inc.
HSTMHealthStream, Inc.
AUGXAugmedix, Inc.
HCATHealth Catalyst, Inc.

RNLX Ownership FAQ


Renalytix is owned by institutional shareholders (5.16%), insiders (4.51%), and public (90.33%). The largest institutional shareholder of Renalytix is PINNACLE ASSOCIATES LTD (1.67% of total shares) and the top mutual fund owner is ALGER INSTITUTIONAL FUNDS (0.28% of total shares).

Renalytix's major institutional shareholders are PINNACLE ASSOCIATES LTD, STIFEL FINANCIAL CORP, LEVIN CAPITAL STRATEGIES, L.P., TEJARA CAPITAL LTD, and CI PRIVATE WEALTH, LLC. The top five shareholders own together 5.67% of the company's share outstanding.

As of Jun 2024, there are 13 institutional shareholders of Renalytix.

PINNACLE ASSOCIATES LTD owns 815.42K shares of Renalytix, representing 1.67% of the company's total shares outstanding, valued at $188.36K (as of Jun 2024).

As of Jun 2024, STIFEL FINANCIAL CORP holds 561K shares of Renalytix (RNLX), compromising 1.15% of the company, valued at $129.59K.

LEVIN CAPITAL STRATEGIES, L.P is the third largest holder of Renalytix. The company owns 555K of the company's shares outstanding (worth $128.2K).